| IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy V Suppiah, M Moldovan, G Ahlenstiel, T Berg, M Weltman, ML Abate, ... Nature genetics 41 (10), 1100-1104, 2009 | 2377 | 2009 |
| Natural history of early primary biliary cirrhosis JV Metcalf, HC Mitchison, JM Palmer, DE Jones, MF Bassendine, ... The Lancet 348 (9039), 1399-1402, 1996 | 575 | 1996 |
| Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients SU Nielsen, MF Bassendine, AD Burt, C Martin, W Pumeechockchai, ... Journal of virology 80 (5), 2418-2428, 2006 | 462 | 2006 |
| Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study G Dusheiko, J Main, H Thomas, O Reichard, C Lee, A Dhillon, S Rassam, ... Journal of hepatology 25 (5), 591-598, 1996 | 456 | 1996 |
| Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis J Grove, AK Daly, MF Bassendine, CP Day Hepatology 26 (1), 143-146, 1997 | 390 | 1997 |
| Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens SJ Yeaman, DJ Danner, DJ Mutimer, SPM Fussey, OFW James, ... The Lancet 331 (8594), 1067-1070, 1988 | 354 | 1988 |
| Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. SP Fussey, JR Guest, OF James, MF Bassendine, SJ Yeaman Proceedings of the National Academy of Sciences 85 (22), 8654-8658, 1988 | 346 | 1988 |
| Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. P Michieletti, IR Wanless, A Katz, PJ Scheuer, SJ Yeaman, ... Gut 35 (2), 260-265, 1994 | 311 | 1994 |
| Familial primary biliary cirrhosis reassessed: a geographically-based population study DEJ Jones, FE Watt, JV Metcalf, MF Bassendine, OFW James Journal of hepatology 30 (3), 402-407, 1999 | 279 | 1999 |
| Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? HC Mitchison, MF Bassendine, A Hendrick, MK Bennett, G Bird, ... Hepatology 6 (6), 1279-1284, 1986 | 271 | 1986 |
| Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C BC Smith, J Grove, MA Guzail, CP Day, AK Daly, AD Burt, MF Bassendine Hepatology 27 (6), 1695-1699, 1998 | 256 | 1998 |
| Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease J Grove, AK Daly, MF Bassendine, E Gilvarry, CP Day Gut 46 (4), 540-545, 2000 | 255 | 2000 |
| A controlled trial of prednisolone treatment in primary biliary cirrhosis: three-year results HC Mitchison, JM Palmer, MF Bassendine, AJ Watson, CO Record, ... Journal of hepatology 15 (3), 336-344, 1992 | 253 | 1992 |
| A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis S Stewart, M Prince, M Bassendine, M Hudson, O James, D Jones, ... Journal of hepatology 47 (2), 277-283, 2007 | 242 | 2007 |
| The true impact of fatigue in primary biliary cirrhosis: a population study J Goldblatt, PJS Taylor, T Lipman, MI Prince, A Baragiotta, ... Gastroenterology 122 (5), 1235-1241, 2002 | 239 | 2002 |
| CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis K Agarwal, DEJ Jones, AK Daly, OFW James, B Vaidya, S Pearce, ... Journal of hepatology 32 (4), 538-541, 2000 | 239 | 2000 |
| Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage CP Day, R Bashir, OFW James, MF Bassendine, DW Crabb, ... Hepatology 14 (5), 798-801, 1991 | 211 | 1991 |
| Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies J Grove, S Nielsen, J Zhong, MF Bassendine, HE Drummer, P Balfe, ... Journal of virology 82 (24), 12020-12029, 2008 | 195 | 2008 |
| A pilot, double‐blind, controlled 1‐year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss HC Mitchison, MF Bassendine, AJ Malcolm, AJ Watson, CO Record, ... Hepatology 10 (4), 420-429, 1989 | 195 | 1989 |
| Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. SP Fussey, ST Ali, JR Guest, OFW James, MF Bassendine, SJ Yeaman Proceedings of the National Academy of Sciences 87 (10), 3987-3991, 1990 | 190 | 1990 |
